Bausch Health Companies Inc

Bausch Health Companies Inc. operates as a diversified pharmaceutical company. It develops manufactures and markets a range of products primarily in gastroenterology hepatology neurology dermatology international pharmaceuticals and eye health. The company operates through five segments: Salix International Solta Medical Diversified and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices branded pharmaceuticals generic pharmaceuticals and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care surgical and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. was incorporated in 2013 and is headquartered in Laval Canada.